SUNPHARMA

Sun Pharmaceutical Ind L · ISIN INE044A01036 · Health Technology

Margin Trading Facility book for SUNPHARMA across NSE and BSE. Free to use — no signup, no paywall. All figures in ₹ crore, derived from NSE and BSE public disclosures.

Funded value
₹221 Cr
as of 23 Jul 2026
Rank in book
#146
365 days tracked
Share of book
0.15%
of the whole NSE + BSE book
Peak funded
₹277 Cr
on 09 Jun 2026
NSE
₹218 Cr
BSE
₹3 Cr
Largest single-day addition
+₹108 Cr
on 26 May 2026
Largest single-day unwind
−₹90 Cr
on 10 Mar 2026

SUNPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole market book, and rank. Newest first.
DateCombinedDay ΔNSEBSE% of bookRank
23 Jul 2026₹221 Cr+₹0₹218₹30.15%146
22 Jul 2026₹221 Cr+₹1₹218₹30.15%143
21 Jul 2026₹220 Cr−₹5₹218₹20.15%144
20 Jul 2026₹225 Cr−₹2₹223₹20.16%143
17 Jul 2026₹226 Cr+₹1₹224₹20.16%142
16 Jul 2026₹226 Cr+₹0₹224₹20.16%143
15 Jul 2026₹226 Cr+₹0₹224₹20.16%143
14 Jul 2026₹225 Cr−₹3₹223₹20.16%142
13 Jul 2026₹229 Cr+₹1₹226₹20.16%140
10 Jul 2026₹227 Cr+₹2₹225₹20.16%140
09 Jul 2026₹225 Cr−₹14₹223₹20.16%144
08 Jul 2026₹239 Cr−₹2₹236₹30.17%135
07 Jul 2026₹240 Cr+₹8₹237₹30.17%133
06 Jul 2026₹232 Cr+₹1₹229₹30.17%139
03 Jul 2026₹231 Cr−₹8₹228₹30.17%137
02 Jul 2026₹239 Cr−₹1₹235₹40.17%135
01 Jul 2026₹240 Cr−₹1₹236₹40.17%138
30 Jun 2026₹241 Cr+₹2₹237₹40.17%136
29 Jun 2026₹239 Cr−₹4₹235₹40.17%135
25 Jun 2026₹243 Cr−₹0₹239₹40.17%135
24 Jun 2026₹243 Cr+₹2₹239₹40.17%135
23 Jun 2026₹241 Cr−₹8₹238₹40.17%138
22 Jun 2026₹250 Cr−₹9₹245₹50.18%132
19 Jun 2026₹259 Cr−₹9₹254₹50.19%121
18 Jun 2026₹268 Cr−₹1₹263₹50.20%116
17 Jun 2026₹270 Cr+₹0₹264₹50.20%114
16 Jun 2026₹270 Cr+₹1₹264₹50.20%115
15 Jun 2026₹268 Cr+₹0₹263₹50.20%115
12 Jun 2026₹268 Cr−₹5₹262₹50.20%115
11 Jun 2026₹273 Cr₹267₹60.20%114

IndiaMTF is an independent informational project. It is not a brokerage, is not affiliated with NSE, BSE or any SEBI-registered entity, and does not provide investment advice. Figures are derived from NSE and BSE public disclosures and may be revised or restated by the exchanges. Verify against the primary source before acting on anything here.